EUVIMEDEUVIMED entdecken
Crossref

Impact of Early Resumption of Oral Anticoagulation on Recurrence After Surgery for Chronic Subdural Hematoma in Patients With Atrial Fibrillation: A Target Trial Emulation

Takayuki Anno, Toshiki Fukasawa, Tomohiro Shinozaki iD, Masato Takeuchi, Satomi Yoshida, Koji Kawakami iD

Pharmacoepidemiology and Drug Safety · 2024

DOI: 10.1002/pds.70063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2024. Verfasst von Takayuki Anno und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Atrial Fibrillation, Hematoma, Subdural, Chronic, Anticoagulants, Recurrence. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Clinicians treating patients with atrial fibrillation (AF) on oral anticoagulants who undergo surgery for chronic subdural hematoma (CSDH) face a dilemma: while early postoperative resumption of anticoagulation is necessary to prevent embolism, it may increase the risk of CSDH recurrence. To date, however, no study has evaluated this question while adequately addressing common biases in observational studies. Here, we assessed this issue using target trial emulation framework.

Methods

We identified patients undergoing initial CSDH surgery who had received anticoagulation for AF preoperatively from two hospital‐based administrative databases (2014–2022). We compared two treatment strategies: resumption of anticoagulation within 14 days postoperatively versus no resumption during this period. Using a three‐step method of cloning, censoring, and weighting, we estimated the risk of CSDH recurrence, along with the risk ratio and risk difference at postoperative day 90.

Results

291 CSDH patients with AF were eligible, of whom 29 (10.0%) underwent CSDH reoperation. The weighted estimated 90‐day reoperation risk was 11.7% (95% confidence interval [CI], 6.0 to 14.3) for resuming anticoagulation within 14 days postoperatively and 9.4% (95% CI, 4.1 to 12.8) for not resuming within 14 days, corresponding to a risk ratio of 1.20 (95% CI, 0.67 to 2.36) and risk difference of 1.9% (95% CI, −4.0 to 6.6).

Conclusions

90‐day risk of CSDH recurrence may not differ between early and non‐early resumption of anticoagulation, although early resumption could modestly accelerate recurrence. Allowing for the imprecision of the estimates, these findings provide important insights for clinical decision‐making regarding anticoagulation resumption.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationHematoma, Subdural, ChronicAnticoagulantsRecurrenceHumansAgedFemaleMaleAdministration, OralAged, 80 and overMiddle AgedReoperationTime FactorsDatabases, FactualRetrospective Studies

Stichwörter der Autor:innen

anticoagulationatrial fibrillationchronic subdural hematomareal‐world datarecurrencetarget trial emulation

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
  • Department of Digital Health and Epidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
  • Department of Information and Computer Technology, Faculty of Engineering, Tokyo University of Science, Tokyo, Japan.
  • Graduate School of Public Health, Shizuoka Graduate University of Public Health, Shizuoka, Japan.
  • Department of Clinical Medicine, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.

ORCID-Profile: Tomohiro Shinozaki, Koji Kawakami

Zitieren

APA

Anno, T., Fukasawa, T., Shinozaki, T., Takeuchi, M., Yoshida, S., & Kawakami, K. (2024). Impact of Early Resumption of Oral Anticoagulation on Recurrence After Surgery for Chronic Subdural Hematoma in Patients With Atrial Fibrillation: A Target Trial Emulation. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70063

Vancouver

Anno T, Fukasawa T, Shinozaki T, Takeuchi M, Yoshida S, Kawakami K. Impact of Early Resumption of Oral Anticoagulation on Recurrence After Surgery for Chronic Subdural Hematoma in Patients With Atrial Fibrillation: A Target Trial Emulation. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.70063

BibTeX
@article{Anno2024,
  author = {Anno, Takayuki and Fukasawa, Toshiki and Shinozaki, Tomohiro and Takeuchi, Masato and Yoshida, Satomi and Kawakami, Koji},
  title = {Impact of Early Resumption of Oral Anticoagulation on Recurrence After Surgery for Chronic Subdural Hematoma in Patients With Atrial Fibrillation: A Target Trial Emulation},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2024},
  doi = {10.1002/pds.70063}
}
Kostenlos starten →